Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT03195270 | Use of PET/MR Imaging in Chronic Pain | PHASE1 | COMPLETED | 88 | — | — | Nov 24, 2014 | Jan 20, 2022 | May 16, 2023 | 1 | United States |
Identification of structures with increased \[18F\]FDG uptake (SUVmax) corresponding to pain.
| Arm | Type | Description |
|---|---|---|
| Single Arm | EXPERIMENTAL | \[18F\]FDG PET/MRI |
| Name | Type | Description |
|---|---|---|
| [18F]FDG | DRUG | 10 mCi of \[18F\]FDG via the antecubital vein in a bolus injection |
| PET/MRI | DEVICE | PET/MRI hybrid scanner used as diagnostic device |
Inclusion Criteria: * Age 18 years or older. * Chronic pain lasting greater than 2 months. For example: Low back pain, sciatica, complex regional pain syndrome, peripheral nerve injury, fibromyalgia, neuropathy, osteoarthritis, cancer pain, persistent post-operative pain, and migraine. * Provides i...